Assignee
REVANCE THERAPEUTICS INC
US·19 granted patents·48 pending applications·147 citations·filing 2001–2025
Top patents by PatentIndex Score
67 records- 0197US9469849B2Methods and systems for purifying non-complexed botulinum neurotoxinREVANCE THERAPEUTICS INC·Filed 2015·Granted Oct 18, 2016·23 cites·67 claims
- 0296US9211248B2Compositions and methods for topical application and transdermal delivery of botulinum toxinsREVANCE THERAPEUTICS INC·Filed 2013·Granted Dec 15, 2015·21 cites·76 claims
- 0395US10201594B2Compositions and methods for safe treatment of rhinitisREVANCE THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·14 cites·8 claims
- 0495US10111939B2Albumin-free botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2016·Granted Oct 30, 2018·16 cites·38 claims
- 0594US10080786B2Methods for treating pain by topical application and transdermal delivery of botulinum toxinREVANCE THERAPEUTICS INC·Filed 2015·Granted Sep 25, 2018·12 cites·45 claims
- 0692US9901627B2Topical ocular preparation of botulinum toxin for use in ocular surface diseaseREVANCE THERAPEUTICS INC·Filed 2015·Granted Feb 27, 2018·5 cites·31 claims
- 0792US8022179B2Compositions and methods for topical application and transdermal delivery of an oligopeptideREVANCE THERAPEUTICS INC·Filed 2006·Granted Sep 20, 2011·17 cites·26 claims
- 0889US10744078B2Compositions and methods for topical application and transdermal delivery of botulinum toxinsREVANCE THERAPEUTICS INC·Filed 2018·Granted Aug 18, 2020·5 cites·20 claims
- 0988US7807780B2Multi-component biological transport systemsREVANCE THERAPEUTICS INC·Filed 2001·Granted Oct 5, 2010·28 cites·6 claims
- 1088US2024108700A1Methods of Treating a Spastic Disorder in a Subject Having Underlying Condition(s)REVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1188US2024382571A1Albumin-Free Botulinum Toxin FormulationsREVANCE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1288US2024100135A1Methods of Treating an Optic Disease in a SubjectREVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1387US2024000906A1Methods of Treating or Preventing Migraine or Repetitive Occurrence of Common Migraine Headaches in a Subject Having Underlying Condition(s)REVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1485US11351232B2Albumin-free botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2018·Granted Jun 7, 2022·1 cites·19 claims
- 1585US9950042B2Extended length botulinum toxin formulation for human or mammalian useREVANCE THERAPEUTICS INC·Filed 2015·Granted Apr 24, 2018·4 cites·17 claims
- 1683US2024058628A1Injectable botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1781US10441641B2Botulinum toxin and the treatment of primary disorders of mood and affectREVANCE THERAPEUTICS INC·Filed 2015·Granted Oct 15, 2019·1 cites·9 claims
- 1879US2020078450A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1978US2025064905A1Injectable botulinum toxin formulations and methods of use thereof having high response rate and long effect durationREVANCE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2077US11911449B2Albumin-free botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2021·Granted Feb 27, 2024·0 cites·14 claims
- 2177US11466262B2Methods and systems for purifying non-complexed botulinum neurotoxinREVANCE THERAPEUTICS INC·Filed 2019·Granted Oct 11, 2022·0 cites·23 claims
- 2277US2021308236A1Botulinum toxin and the treatment of primary disorders of mood and affectREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2376US12257293B2Methods of treatment for cervical dystoniaREVANCE THERAPEUTICS INC·Filed 2021·Granted Mar 25, 2025·0 cites·9 claims
- 2476US2021252116A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2576US2021283228A1Botulinum toxin and the treatment of primary disorders of mood and affectREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2675US2017143807A9Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2774US2010166689A1Compositions and Methods for Treating HyperpigmentationREVANCE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2873US2021069224A1Compositions and Methods for Topical and Diagnostic and Therapeutic TransportREVANCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2973US2020101097A1Compositions and Methods for Topical and Diagnostic and Therapeutic TransportREVANCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3072US2025319168A1Methods of treatment for cervical dystoniaREVANCE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3171US2025332232A1Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disordersREVANCE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3269US2017165331A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3369US2017165330A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3468US2024216486A1Injectable botulinum toxin methods for treating headachesREVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3567US11471708B2Injectable botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2019·Granted Oct 18, 2022·0 cites·13 claims
- 3667US2021189326A1Methods and kits for topical application, removal, and inactivation of therapeutic or cosmetic toxin compositionsREVANCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3767US2017333537A9Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3866US2022062400A1Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic EffectREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3966US2023390368A1Methods of Treating Cervical Dystonia in a Subject Having Underlying Condition(s)REVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4064US2020345819A1Compositions and Methods for Safe Treatment of RhinitisREVANCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4164US2017029795A1Methods and Systems for Purifying Non-Complexed Botulinum NeurotoxinREVANCE THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4264US2014120077A1Compositions and Methods for Safe Treatment of RhinitisREVANCE THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4363US2020179498A1Methods of treatment for cervical dystoniaREVANCE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4462US2020384090A1Injectable botulinum toxin formulations and methods of use thereof having high response rate and long effect durationREVANCE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4559US10857215B2Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory bedsREVANCE THERAPEUTICS INC·Filed 2015·Granted Dec 8, 2020·0 cites·29 claims
- 4658US2018214717A1Injectable botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4757US2023210963A1Injectable botulinum toxin methos for treating headachesREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4857US2008226551A1Transport Molecules Using Reverse Sequence HIV-TAT PolypeptidesREVANCE THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 4957US2025268996A1Methods of and compositions for treatment of upper limb spasticityREVANCE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 5057US2010093639A1Transport Molecules Using Reverse Sequence HIV-TAT PolypeptidesREVANCE THERAPEUTICS INC·Filed 2007·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →